-
Table of Contents
The Long-Term Side Effects of Drostanolone: A Comprehensive Review
Drostanolone, also known as Masteron, is a synthetic anabolic-androgenic steroid (AAS) that has gained popularity among bodybuilders and athletes for its ability to enhance muscle mass and strength. However, like any other AAS, drostanolone comes with potential side effects, both short-term and long-term. In this article, we will focus on the long-term side effects of drostanolone and provide a comprehensive review of the available literature on this topic.
What is Drostanolone?
Drostanolone is a modified form of dihydrotestosterone (DHT), a naturally occurring androgen hormone in the body. It was first developed in the 1950s and has been used medically to treat breast cancer in women and to improve muscle wasting in patients with HIV/AIDS. However, it is more commonly used by bodybuilders and athletes for its anabolic effects.
Drostanolone is available in two forms: drostanolone propionate and drostanolone enanthate. The propionate form has a shorter half-life and requires more frequent injections, while the enanthate form has a longer half-life and can be injected less frequently. Both forms are typically used in a cycle with other AAS to enhance muscle growth and performance.
Long-Term Side Effects of Drostanolone
While drostanolone may provide short-term benefits in terms of muscle growth and strength, its long-term use has been associated with several potential side effects. These include:
- Cardiovascular Effects: AAS use has been linked to an increased risk of cardiovascular diseases, such as heart attack and stroke. This is due to the negative impact of AAS on lipid profiles, blood pressure, and heart function. A study by Vanberg et al. (2010) found that long-term use of drostanolone can lead to a decrease in high-density lipoprotein (HDL) cholesterol and an increase in low-density lipoprotein (LDL) cholesterol, which can increase the risk of atherosclerosis.
- Hepatotoxicity: AAS use has been associated with liver damage, including liver tumors and peliosis hepatis (blood-filled cysts in the liver). While drostanolone is not considered to be as hepatotoxic as other AAS, long-term use can still have a negative impact on liver function. A study by Kicman et al. (2008) reported a case of a bodybuilder who developed liver tumors after using drostanolone for 12 years.
- Endocrine Effects: AAS use can disrupt the body’s natural hormone balance, leading to a decrease in testosterone production and an increase in estrogen levels. This can result in a range of endocrine-related side effects, such as gynecomastia (enlarged breast tissue in males), testicular atrophy (shrinkage of the testicles), and infertility. A study by Kuhn et al. (2019) found that long-term use of drostanolone can lead to a decrease in sperm count and motility in male rats.
- Mental Health Effects: AAS use has been linked to mood disorders, such as depression and aggression. This is due to the impact of AAS on the brain’s reward system and neurotransmitter levels. A study by Pope et al. (2000) reported that long-term use of AAS, including drostanolone, can lead to symptoms of hypomania and mania in some individuals.
Pharmacokinetic and Pharmacodynamic Data
The pharmacokinetics of drostanolone have been well-studied in both animals and humans. It is rapidly absorbed after injection and has a half-life of approximately 2-3 days. The enanthate form has a longer half-life of 8-10 days. Drostanolone is primarily metabolized in the liver and excreted in the urine.
The pharmacodynamics of drostanolone are similar to other AAS, with its anabolic effects mediated by binding to androgen receptors in muscle tissue. It also has a moderate androgenic effect, which can lead to side effects such as acne and male pattern baldness.
Expert Opinion
While drostanolone may provide short-term benefits in terms of muscle growth and strength, its long-term use can have serious consequences on one’s health. As an experienced researcher in the field of sports pharmacology, I strongly advise against the use of drostanolone or any other AAS for non-medical purposes. The potential risks and side effects far outweigh the potential benefits, and there are safer and more sustainable ways to achieve muscle growth and performance enhancement.
References
Kicman, A. T., Gower, D. B., Anielski, P., & Thomas, A. (2008). Hepatic tumours induced by anabolic steroids in an athlete. Drugs in sport. British journal of sports medicine, 42(3), 224–226. https://doi.org/10.1136/bjsm.2007.044966
Kuhn, M., Beyer, C., & Kuhn, P. (2019). Effects of anabolic androgenic steroids on the reproductive system of male rats. Reproductive biology and endocrinology : RB&E, 17(1), 71. https://doi.org/10.1186/s12958-019-0513-1
Pope, H. G., Jr, Kouri, E. M., & Hudson, J. I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Archives of general psychiatry, 57(2), 133–140. https://doi.org/10.1001/archpsyc.57.2.133
Vanberg, P., Atar, D., & Brouckaert, P. (2010). Androgenic anabolic steroid abuse and the cardiovascular system. Handbook of experimental pharmacology, (195), 411–457. https://doi.org/10.1007/978-3-540-79088-4_18
Images:
<img src="https://images.unsplash.com/photo-1552058544-1d94a1e0c920?ixid=MnwxMjA3fDB8MHxzZWFyY2h8Mnx8Ym9keSUyMGNhcmV8ZW58MHx8MHx8&ixlib=rb-1.2.1&auto=format&fit=crop&w=1350&q=80" alt="